Page last updated: 2024-08-25

5-hydroxymethylcytosine and Pheochromocytoma

5-hydroxymethylcytosine has been researched along with Pheochromocytoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayley, JP; Bovée, JV; Breuning, MH; Briaire-de Bruijn, IH; Cornelisse, CJ; de Graaff, MA; Devilee, P; Frizzell, N; Hoekstra, AS; Hogendoorn, PC; Korpershoek, E; Kunst, HP; Ras, C; Seifar, RM; Suijker, J; van Minderhout, I1

Other Studies

1 other study(ies) available for 5-hydroxymethylcytosine and Pheochromocytoma

ArticleYear
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
    Oncotarget, 2015, Nov-17, Volume: 6, Issue:36

    Topics: 5-Methylcytosine; Adrenal Gland Neoplasms; Cell Nucleus; Cytosine; Fumarate Hydratase; Gene Silencing; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Immunohistochemistry; Mixed Function Oxygenases; Paraganglioma; Pheochromocytoma; Proto-Oncogene Proteins; Smooth Muscle Tumor; Succinate Dehydrogenase

2015